Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

13 Apr 2010 10:16

RNS Number : 0935K
Byotrol PLC
13 April 2010
 

13 April 2010

 

Byotrol plc

 

Grant of Options

 

Byotrol plc ('Byotrol' or the 'Company'), the leading anti-microbial hygiene company, announced on 25 March 2010 that Dr Gary Millar had been appointed as Chief Executive Officer with effect from 1 April 2010. The Company today announces that the Board has granted Dr Millar options over 400,000 ordinary shares, representing 0.48 per cent. of the issued share capital of the Company, in accordance with the Company's Enterprise Management Incentive Scheme upon the recommendation of the Company's Remuneration Committee.

 

All share options are exercisable at 17 pence per ordinary share, based on the closing mid-market price of the Company's shares yesterday.

 

300,000 of the options are exercisable between 1 April 2013 and 12 April 2020. The performance conditions attaching to these options are that 50 per cent. of the granted options will be exercisable only if the Company's share price has reached 30 pence per share and remained so for 30 consecutive days between 13 April 2010 and 12 April 2020. The remaining 50 per cent. will be exercisable only if the Company's share price has reached 50 pence per share and remained so for 30 consecutive days between 13 April 2010 and 12 April 2020.

The balance of 100,000 options is subject to operational performance conditions relating to the financial year to 31 March 2011, set by the Remuneration Committee, and is exercisable between 1 April 2011 and 12 April 2020. Dr Millar has no cash bonus scheme for the financial year to 31 March 2011.

 

Enquiries:

 

Byotrol plc 0161 277 9518

Ralph Kugler, Non-Executive Chairman

Richard Bell, Finance Director

 

 

Charles Stanley Securities 020 7149 6000

Nominated Adviser

Russell Cook / Carl Holmes

 

Winningtons 020 3043 4162

Tom Cooper / Paul Vann 0797 122 1972

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSMMGMDLFDGGZG
Date   Source Headline
30th Apr 20247:00 amRNSCancellation - Byotrol Plc
29th Apr 20242:15 pmRNSSecondary Trading on Asset Match
23rd Apr 20246:00 pmRNSByotrol
22nd Apr 20244:44 pmRNSCapital Reorganisation Delay
22nd Apr 20241:27 pmRNSResults of General Meeting
15th Apr 202411:48 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20243:27 pmRNSDirector Dealing
28th Mar 20247:00 amRNSProposed Cancellation
22nd Dec 202311:44 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSHalf-year Report
14th Nov 20237:00 amRNSLaunch of PROCESSUS® Instrument Decontamination
14th Nov 20237:00 amRNSTrading Update
9th Nov 20233:43 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSBoard Changes
13th Sep 20233:33 pmRNSResult of AGM
8th Sep 20234:33 pmRNSDirector Dealing
7th Sep 20237:01 amRNSBoard Appointment
7th Sep 20237:00 amRNSTrading Update
29th Aug 20238:51 amRNSLaunch of CHEMGENE MEDLAB into human healthcare
23rd Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSFinal Results
6th Jul 20237:00 amRNSPatent Grant for Novel Anti-viral Seaweed Extract
24th May 20233:14 pmRNSUS EPA approves Byotrol24 as long-lasting virucide
24th May 20238:51 amRNSDirector Dealing
28th Apr 20239:57 amRNSDirector Dealing
27th Apr 20237:00 amRNSTrading Update and Board Changes
1st Feb 20239:52 amRNSDirector Dealing
22nd Dec 20223:08 pmRNSDirector Dealing
19th Dec 202210:00 amRNSDirector Dealing
16th Dec 20227:00 amRNSGrant of Share Incentive Awards
12th Dec 20227:00 amRNSInterim results and Investor Presentation
22nd Nov 20227:00 amRNSDirectorate Changes
27th Sep 202211:15 amRNSPDMR Shareholding
22nd Sep 20225:21 pmRNSResult of AGM
8th Sep 20227:00 amRNSDirector Dealing
2nd Sep 202210:02 amRNSInvestor Presentation
30th Aug 20227:00 amRNSFinal Results
12th Aug 20223:30 pmRNSDirector Dealing
28th Jul 20227:00 amRNSCompletion of Convertible Loan Note Fundraising
11th Jul 20227:00 amRNSTrading Update and Notice of Results
22nd Apr 20229:14 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSTrading Update
12th Jan 20227:00 amRNSSenior Management Appointment
14th Dec 20219:06 amRNSSecond Price Monitoring Extn
14th Dec 20219:00 amRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSDirectorate Change
9th Dec 20218:51 amRNSDirector Dealing
8th Dec 20217:00 amRNSInterim Results and Investor Presentation
2nd Nov 20217:00 amRNSDirectorate and Senior Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.